Endothelial permeability is increased by the supernatant of peripheral blood mononuclear cells stimulated with HLA Class II antibody

Transfusion

Volumn 48, Issue 10, 2008, Pages 2060-2068

  Wakamoto, Shinobu ^b   Fujihara, Mitsuhiro ^a   Sakagawa, Hisako ^b   Takahashi, Daisuke ^b   Niwa, Koichi ^b   Morioka, Masanobu ^b   Sato, Shinichiro ^b   Kato, Toshiaki ^b   Azuma, Hiroshi ^b   Ikeda, Hisami ^b  

^a JAPANESE RED CROSS SOCIETY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL MEMBRANE PERMEABILITY; CELL STIMULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MEDIATOR RELEASE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; SUPERNATANT;

ANTIBODIES; ANTIGEN-ANTIBODY REACTIONS; BLOOD TRANSFUSION; CAPILLARIES; CAPILLARY PERMEABILITY; CELLS, CULTURED; ENDOTHELIAL CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-1BETA; LEUKOCYTES, MONONUCLEAR; NEUTRALIZATION TESTS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS;

EID: 52949100526     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.01809.x     Document Type: Article

References (42)

1. Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev 2006 86 : 279 367.
2. Geiger TL, Howard SC. Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice? Transfus Med Rev 2007 21 : 1 12.
3. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985 25 : 573 7.
4. Holness L, Knippen MA, Simmons L, Lachenbruch PA. Fatalities caused by TRALI. Transfus Med Rev 2004 18 : 184 8.
5. Bux J, Sachs UJ. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 2007 136 : 788 99.
6. Van Buren NL, Stroncek DF, Clay ME, McCullough J, Dalmasso AP. Transfusion-related acute lung injury caused by an NB2 granulocyte-specific antibody in a patient with thrombotic thrombocytopenic purpura. Transfusion 1990 30 : 42 5.
7. Davoren A, Smith OP, Barnes CA, Lawlor E, Evans RG, Lucas GF. Case report: four donors with granulocyte-specific or HLA class I antibodies implicated in a case of transfusion-related acute lung injury (TRALI). Immunohematol 2001 17 : 117 21.
8. Kopko PM, Marshall CS, MacKenzie MR, Holland PV, Popovsky MA. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA 2002 287 : 1968 71.
9. Kopko PM, Popovsky MA, MacKenzie MR, Paglieroni TG, Muto KN, Holland PV. HLA Class II antibodies in transfusion-related acute lung injury. Transfusion 2001 41 : 1244 8.
10. Flesch BK, Neppert J. Transfusion-related acute lung injury caused by human leucocyte antigen Class II antibody. Br J Haematol 2002 116 : 673 6.
11. Kao GS, Wood IG, Dorfman DM, Milford EL, Benjamin RJ. Investigations into the role of anti-HLA Class II antibodies in TRALI. Transfusion 2003 43 : 185 91.
12. Wallis JP, Lubenko A, Wells AW, Chapman CE. Single hospital experience of TRALI. Transfusion 2003 43 : 1053 9.
13. Nicolle AL, Chapman CE, Carter V, Wallis JP. Transfusion-related acute lung injury caused by two donors with anti-human leucocyte antigen Class II antibodies: a look-back investigation. Transfus Med 2004 14 : 225 30.
14. Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood 2005 105 : 2266 73.
15. Kopko PM, Paglieroni TG, Popovsky MA, Muto KN, MacKenzie MR, Holland PV. TRALI: correlation of antigen-antibody and monocyte activation in donor-recipient pairs. Transfusion 2003 43 : 177 84.
16. Seeger W, Schneider U, Kreusler B, von Witzleben E, Walmrath D, Grimminger F, Neppert J. Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood 1990 76 : 1438 44.
17. Sachs UJ, Hattar K, Weissmann N, Bohle RM, Weiss T, Sibelius U, Bux J. Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat lung model. Blood 2006 107 : 1217 9.
18. Wyman TH, Bjornsen AJ, Elzi DJ, Smith CW, England KM, Kelher M, Silliman CC. A two-insult in vitro model of PMN-mediated pulmonary endothelial damage: requirements for adherence and chemokine release. Am J Physiol Cell Physiol 2002 283 : C1592 603.
19. Khan SY, Kelher MR, Heal JM, Blumberg N, Boshkov LK, Phipps R, Gettings KF, McLaughlin NJ, Silliman CC. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006 108 : 2455 62.
20. Silliman CC, Curtis BR, Kopko PM, Khan SY, Kelher MR, Schuller RM, Sannoh B, Ambruso DR. Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model. Blood 2007 109 : 1752 5.
21. Nishimura M, Hashimoto S, Takanashi M, Okazaki H, Satake M, Nakajima K. Role of anti-human leucocyte antigen Class II alloantibody and monocytes in development of transfusion-related acute lung injury. Transfus Med 2007 17 : 129 34.
22. Nishimura M, Hashimoto S, Satake M, Okazaki H, Tadokoro K. Interference with TRALI-causing anti-HLA DR alloantibody induction of human pulmonary microvascular endothelial cell injury by purified soluble HLA DR. Vox Sang 2007 93 : 78 82.
23. Nooteboom A, Van Der Linden CJ, Hendriks T. Tumor necrosis factor-α and interleukin-1β mediate endothelial permeability induced by lipopolysaccharide-stimulated whole blood. Crit Care Med 2002 30 : 2063 8.
24. Nooteboom A, Bleichrodt RP, Hendriks T. Modulation of endothelial monolayer permeability induced by plasma obtained from lipopolysaccharide- stimulated whole blood. Clin Exp Immunol 2006 144 : 362 9.
25. Burke-Gaffney A, Keenan AK. Modulation of human endothelial cell permeability by combinations of the cytokines interleukin-1α/β, tumor necrosis factor-α and interferon-γ. Immunopharmacology 1993 25 : 1 9.
26. Sakagawa H, Miyazaki T, Fujihara M, Sato S, Yamaguchi M, Fukai K, Morioka M, Kato T, Azuma H, Ikeda H. Generation of inflammatory cytokines and chemokines from peripheral blood mononuclear cells by HLA Class II antibody-containing plasma unit that was associated with severe nonhemolytic transfusion reactions. Transfusion 2007 47 : 154 61.
27. Maruo N, Morita I, Shirao M, Murota S. IL-6 increases endothelial permeability in vitro. Endocrinology 1992 131 : 710 4.
28. Fukumoto T, Matsukawa A, Yoshimura T, Edamitsu S, Ohkawara S, Takagi K, Yoshinaga M. IL-8 is an essential mediator of the increased delayed-phase vascular permeability in LPS-induced rabbit pleurisy. J Leukoc Biol 1998 63 : 584 90.
29. Sedgwick JB, Menon I, Gern JE, Busse WW. Effects of inflammatory cytokines on the permeability of human lung microvascular endothelial cell monolayers and differential eosinophil transmigration. J Allergy Clin Immunol 2002 110 : 752 6.
30. Ferrari G, Yan CY, Greene LA. N-acetylcysteine (D- and L-stereoisomers) prevents apoptotic death of neuronal cells. J Neurosci 1995 15 : 2857 66.
31. Stefanec T. Endothelial apoptosis: could it have a role in the pathogenesis and treatment of disease? Chest 2000 117 : 841 54.
32. Wallach D. Cell death induction by TNF: a matter of self control. Trends Biochem Sci 1997 22 : 107 9.
33. Pohlman TH, Harlan JM. Human endothelial cell response to lipopolysaccharide, interleukin-1, and tumor necrosis factor is regulated by protein synthesis. Cell Immunol 1989 119 : 41 52.
34. Madge LA, Li JH, Choi J, Pober JS. Inhibition of phosphatidylinositol 3-kinase sensitizes vascular endothelial cells to cytokine-initiated cathepsin-dependent apoptosis. J Biol Chem 2003 278 : 21295 306.
35. Madge LA, Pober JS. A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFκB in human endothelial cells. J Biol Chem 2000 275 : 15458 65.
36. Xia P, Wang L, Gamble JR, Vadas MA. Activation of sphingosine kinase by tumor necrosis factor-α inhibits apoptosis in human endothelial cells. J Biol Chem 1999 274 : 34499 505.
37. Beck GC, Yard BA, Breedijk AJ, Van Ackern K, Van Der Woude FJ. Release of CXC-chemokines by human lung microvascular endothelial cells (LMVEC) compared with macrovascular umbilical vein endothelial cells. Clin Exp Immunol 1999 118 : 298 303.
38. Burg J, Krump-Konvalinkova V, Bittinger F, Kirkpatrick CJ. GM-CSF expression by human lung microvascular endothelial cells: in vitro and in vivo findings. Am J Physiol Lung Cell Mol Physiol 2002 283 : L460 7.
39. Hillyer P, Mordelet E, Flynn G, Male D. Chemokines, chemokine receptors and adhesion molecules on different human endothelia: discriminating the tissue-specific functions that affect leucocyte migration. Clin Exp Immunol 2003 134 : 431 41.
40. Otto M, Bittinger F, Kriegsmann J, Kirkpatrick CJ. Differential adhesion of polymorphous neutrophilic granulocytes to macro- and microvascular endothelial cells under flow conditions. Pathobiology 2001 69 : 159 71.
41. Shelton JL, Wang L, Cepinskas G, Sandig M, Inculet R, McCormack DG, Mehta S. Albumin leak across human pulmonary microvascular vs. umbilical vein endothelial cells under septic conditions. Microvasc Res 2006 71 : 40 7.
42. Furuhata S, Ando K, Oki M, Aoki K, Ohnishi S, Aoyagi K, Sasaki H, Sakamoto H, Yoshida T, Ohnami S. Gene expression profiles of endothelial progenitor cells by oligonucleotide microarray analysis. Mol Cell Biochem 2007 298 : 125 38.